Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avadel Pharmaceuticals (AVDL) Return on Sales (2016 - 2020)

Historic Return on Sales for Avadel Pharmaceuticals (AVDL) over the last 13 years, with Q1 2021 value amounting to 0.08%.

  • Avadel Pharmaceuticals' Return on Sales rose 9300.0% to 0.08% in Q1 2021 from the same period last year, while for Mar 2021 it was 0.08%, marking a year-over-year increase of 14100.0%. This contributed to the annual value of 0.28% for FY2020, which is 10000.0% up from last year.
  • Latest data reveals that Avadel Pharmaceuticals reported Return on Sales of 0.08% as of Q1 2021, which was up 9300.0% from 0.29% recorded in Q4 2020.
  • In the past 5 years, Avadel Pharmaceuticals' Return on Sales ranged from a high of 3.06% in Q2 2020 and a low of 4.14% during Q4 2019
  • For the 5-year period, Avadel Pharmaceuticals' Return on Sales averaged around 0.44%, with its median value being 0.37% (2018).
  • Its Return on Sales has fluctuated over the past 5 years, first crashed by -28200bps in 2018, then surged by 44300bps in 2020.
  • Avadel Pharmaceuticals' Return on Sales (Quarter) stood at 0.24% in 2017, then plummeted by -1187bps to 3.05% in 2018, then tumbled by -36bps to 4.14% in 2019, then surged by 107bps to 0.29% in 2020, then tumbled by -73bps to 0.08% in 2021.
  • Its last three reported values are 0.08% in Q1 2021, 0.29% for Q4 2020, and 1.1% during Q3 2020.